Histopathology Core
Histopathology Core
批准号:
8557111
负责人:
Chi-Chao Chan
金额:
$59.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AutopsyCellsClinicalClinical ResearchCollaborationsConsultationsCore FacilityCytology HistologyDiagnosisElectron MicroscopyElectronicsElectronsGuidelinesHealth Services ResearchHistopathologyImageImmunohistochemistryIn VitroInstitutesIntramural Research ProgramLaboratoriesLicensingLightLiquid substanceMicroscopicMissionOperative Surgical ProceduresPatient CarePatientsPhysiciansProcessPublicationsReportingResearchResearch ActivityResearch PersonnelResearch Project GrantsSamplingSlideSpecimenStaining methodStainsTissuesTransmission Electron MicroscopyUnited States National Institutes of HealthVision researchWorkhuman tissuein vivoresearch studytissue processingtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Histopathology Core of the NEI is devoted to supporting the patient care, vision research, and mission of the NEI and other collaborative institutes at the NIH. This consists of processing human tissues (mainly ocular tissues) removed in surgeries and collected at autopsies. The Core grosses the tissues, sections and stains slides for light and/or transmission electron microscopy. The Histopathology Core serves the Clinical Branch and all NEI laboratories under the NEI Intramural Research Program, as well as other NIH institutes, which perform research involving ocular and related tissues. In addition, the Core receives clinical and experimental specimens submitted by clinicians and investigators outside NIH (USA and abroad) for consultation or collaboration. During FY12, the Histopathology Core received and processed approximately 5340 specimens and yielded over 9336 slides stained. Additionally, the laboratory processed case materials sent for ultrastructure, which produced 1683 electron microscopic images. This fiscal year, 113 clinical cases were also received and processed. The patient specimens produced 1139 histological slides and 94 electronic microscopic images. There are over 20 publications that include work performed by the Core. Although about 95% of our effort is devoted to NEI duties, the Histopathology Core also performs services for research projects inside and outside the NIH. The core follows the guidelines for the conduct of research in the intramural research program at the NIH and other standards set by the NIH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
-
批准号:8938289
-
项目类别:
-
资助金额:$87.77万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
IMMUNOPATHOLOGY IN EYES WITH EXPERIMENTAL AND CLINICAL OCULAR DISEASES
-
批准号:6106829
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Histopathology Core
-
批准号:8938505
-
项目类别:
-
资助金额:$53.92万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Histology Core
-
批准号:7734659
-
项目类别:
-
资助金额:$41.58万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
-
批准号:8339745
-
项目类别:
-
资助金额:$149.47万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Age-Related Macular Degeneration: Genetic Variations and Animal Model
-
批准号:8737634
-
项目类别:
-
资助金额:$79.19万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Histology Core
-
批准号:7970112
-
项目类别:
-
资助金额:$36.31万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Histology Core
-
批准号:8149697
-
项目类别:
-
资助金额:$44.25万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Age-Related Macular Degeneration: Genetic Variations and Animal Model
-
批准号:8339775
-
项目类别:
-
资助金额:$104.89万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Histopathology Core
-
批准号:8339820
-
项目类别:
-
资助金额:$39.51万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
-
批准号:8556804
-
项目类别:
-
资助金额:$100.33万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Age-Related Macular Degeneration: Genetic Variations and Animal Model
-
批准号:8556833
-
项目类别:
-
资助金额:$100.08万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
-
批准号:7968275
-
项目类别:
-
资助金额:$108.1万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
-
批准号:7734588
-
项目类别:
-
资助金额:$131.78万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
-
批准号:8149132
-
项目类别:
-
资助金额:$142.03万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Age-Related Macular Degeneration: Genetic Variations and Animal Model
-
批准号:7968351
-
项目类别:
-
资助金额:$96.16万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
-
批准号:7594042
-
项目类别:
-
资助金额:$228.89万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
-
批准号:8737606
-
项目类别:
-
资助金额:$83.21万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Histopathology Core
-
批准号:8737697
-
项目类别:
-
资助金额:$52.52万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
Age-Related Macular Degeneration: Genetic Variations and Animal Model
-
批准号:8938317
-
项目类别:
-
资助金额:$63.77万
-
财政年份:--
-
负责人:Chi-Chao Chan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: